Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Velneperit
Cat. No.:
OB0225LY-0001
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Velneperit is a specific neuropeptide Y (NPY) Y5 receptor antagonist with potential applications in obesity research.
Synonym:
S2367; 342577-38-2; S-2367; s2367; Velneprit; (1R,4R)-4-((1,1-Dimethylethyl)sulfonamido)-N-(5-(trifluoromethyl)pyridin-2-yl)cyclohexane-1-carboxamide; Rel-(1R,4R)-4-((1,1-Dimethylethyl)sulfonamido)-N-(5-(trifluoromethyl)pyridin-2-yl)cyclohexane-1-carboxamide; N-[5-(Trifluoromethyl)pyridin-2-yl]-trans-4-(tert-butylsulfonylamino)cyclohexane-1-carboxamide; Trans-4-(((1,1-Dimethylethyl)sulfonyl)amino)-N-(5-(trifluoromethyl)pyridin-2-yl)cyclohexanecarboxamide; trans-4-(1,1-Dimethylethylsulfonamido)-N-(5-(trifluoromethyl)pyridin-2-yl)cyclohexanecarboxamide
CAS No.:
342577-38-2
Compound CID:
20629114
Formula:
C17H24F3N3O3S
Formula Weight:
407.45
Specification
Relative Density:
1.31 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Velneperit can be used to modulate neurotransmitter pathways.
Library Information
Targets:
Neuropeptide Y receptor
Receptors:
Neuropeptide Y (NPY) Y5 receptor
Pathways:
GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-1
Plate Location:
a2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
29 mg/mL; 71.17 mM
